脑卒中后痉挛状态是影响患者日常生活能力与运动功能恢复的主要原因[1]。Lance[2]将痉挛状态定义为:一种因牵张反射亢进所致的以速度依赖性肌张力增高为特征的运动障碍,且多伴有腱反射亢进,是上运动神经元综合征的一个组成部分。该定义...脑卒中后痉挛状态是影响患者日常生活能力与运动功能恢复的主要原因[1]。Lance[2]将痉挛状态定义为:一种因牵张反射亢进所致的以速度依赖性肌张力增高为特征的运动障碍,且多伴有腱反射亢进,是上运动神经元综合征的一个组成部分。该定义描述了被动运动模式下的痉挛状态特点,有其局限性,对痉挛状态的定位与描述不够精确。痉挛测量数据库(support program for assembly of a database for spasticity measurement,SPASM)小组将痉挛状态定义为:由上运动神经元病变所引起的感觉运动控制失调,表现为肌肉间歇性或持续性非自主激活[3]。展开更多
Objective To explore the effect of meridian sinew row needling combined with dermal needling on spasticity of post-stroke patients with upper limb hemiparalysis. Methods Four hundred and eighty-eight cases of post-str...Objective To explore the effect of meridian sinew row needling combined with dermal needling on spasticity of post-stroke patients with upper limb hemiparalysis. Methods Four hundred and eighty-eight cases of post-stroke patients with upper limb spasticity were randomly divided into two groups at the ratio of 1: 1, the group of meridian sinew row needling combined with dermal needling (group A, 244 cases) and western medication group (group B, 244 cases). Coupled with rehabilitation, the patients in the group A were given meridian sinew row needling combined with dermal needling where five shu points were specifically selected, and three yang meridians of the hand were treated with acupuncture with muscle region, and three yin meridians of the hand were treated with dermal needles; the patients in the group B was treated with conventional western medication with piracetam injection and cerebroprotein hydrolysate included. Clinical efficacy was evaluated among patients in the two groups after three weeks of continuous treatment, and upper limb spasticity and motor functions were observed through modified Asworth Scale and FugI-Meyer Assessment Scale (FMA) before and after treatment. Results For Asworth Scale, group A was significantly superior to group B (3.04 ± 1.29 vs 3.88 ± 1.54, P〈0.05); for FMA scale, group A was also significantly superior to group B (48.67± 15.64 vs 42.96±14.72, P〈0.05); mitigations of motor status of upper limb joints in group A, such as remission of shoulder adduction (90.5%), pronation of forearm (70.7%), elbow joint flexion (73.1%), wrist joint flexion (80.9%) and finger flexion (88.1%), were superior to those of group B (70.0%, 60.0%, 61.9%, 57.4%, 63.2%, all P〈0.05). Conclusion Good clinical efficacy of the treatment with combined with dermal needling on spasticity of post-stroke patients with upper limb hemiparalysis is achieved.展开更多
文摘脑卒中后痉挛状态是影响患者日常生活能力与运动功能恢复的主要原因[1]。Lance[2]将痉挛状态定义为:一种因牵张反射亢进所致的以速度依赖性肌张力增高为特征的运动障碍,且多伴有腱反射亢进,是上运动神经元综合征的一个组成部分。该定义描述了被动运动模式下的痉挛状态特点,有其局限性,对痉挛状态的定位与描述不够精确。痉挛测量数据库(support program for assembly of a database for spasticity measurement,SPASM)小组将痉挛状态定义为:由上运动神经元病变所引起的感觉运动控制失调,表现为肌肉间歇性或持续性非自主激活[3]。
基金Supported by Hebei Administration of Traditional Chinese Medicine(2009180)
文摘Objective To explore the effect of meridian sinew row needling combined with dermal needling on spasticity of post-stroke patients with upper limb hemiparalysis. Methods Four hundred and eighty-eight cases of post-stroke patients with upper limb spasticity were randomly divided into two groups at the ratio of 1: 1, the group of meridian sinew row needling combined with dermal needling (group A, 244 cases) and western medication group (group B, 244 cases). Coupled with rehabilitation, the patients in the group A were given meridian sinew row needling combined with dermal needling where five shu points were specifically selected, and three yang meridians of the hand were treated with acupuncture with muscle region, and three yin meridians of the hand were treated with dermal needles; the patients in the group B was treated with conventional western medication with piracetam injection and cerebroprotein hydrolysate included. Clinical efficacy was evaluated among patients in the two groups after three weeks of continuous treatment, and upper limb spasticity and motor functions were observed through modified Asworth Scale and FugI-Meyer Assessment Scale (FMA) before and after treatment. Results For Asworth Scale, group A was significantly superior to group B (3.04 ± 1.29 vs 3.88 ± 1.54, P〈0.05); for FMA scale, group A was also significantly superior to group B (48.67± 15.64 vs 42.96±14.72, P〈0.05); mitigations of motor status of upper limb joints in group A, such as remission of shoulder adduction (90.5%), pronation of forearm (70.7%), elbow joint flexion (73.1%), wrist joint flexion (80.9%) and finger flexion (88.1%), were superior to those of group B (70.0%, 60.0%, 61.9%, 57.4%, 63.2%, all P〈0.05). Conclusion Good clinical efficacy of the treatment with combined with dermal needling on spasticity of post-stroke patients with upper limb hemiparalysis is achieved.